Verition Fund Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-640
Closed -$38.8K 2487
2022
Q4
$38.8K Buy
640
+230
+56% +$21.4K ﹤0.01% 1900
2022
Q3
$41K Hold
410
﹤0.01% 2709
2022
Q2
$36K Buy
+410
New +$50.1K ﹤0.01% 2178
2021
Q3
Sell
-494
Closed -$148K 2239
2021
Q2
$148K Sell
494
-173
-26% -$51.5K ﹤0.01% 1651
2021
Q1
$199K Buy
+667
New +$204K ﹤0.01% 1358

Other funds holding RBOT

Verition Fund Management's RBOT Position: Q1 2023 in Review

Verition Fund Management sold out of Vicarious Surgical (RBOT) in Q1 2023, closing a stake of 640 shares — an estimated $38.8K sold.

Verition Fund Management first reported a position in RBOT in Q1 2021 and held it in 5 quarters. The position peaked at $199K in Q1 2021. 79 funds tracked by Wall St. Rank hold RBOT as of Q1 2023.

  • Verition Fund Management reported no remaining Vicarious Surgical position as of Q1 2023 after selling out during the quarter.
  • Verition Fund Management sold 640 Vicarious Surgical shares in Q1 2023, an estimated $38.8K.
  • Verition Fund Management first reported a position in Vicarious Surgical in Q1 2021 and held it in 5 quarters.
  • Verition Fund Management's Vicarious Surgical position peaked at $199K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2023.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.